Clinical assessment of coagulation parameters in whole blood and plasma samples indicates strong correlations with fibrinogen and standard tests.
Acoustic tweezing coagulometry provides containerless coagulation analysis using a small, 4–6 microliter drop of blood. It operates in two regimes: integrated quasi-static acoustic tweezing thromboelastometry (i-QATT), which measures clot firmness and turbidity, and acoustic tweezing spectroscopy (ATS) assessing clot viscoelasticity. In this work, these two techniques were clinically assessed on venous whole blood (WB) and platelet-poor plasma (PPP) samples from non-smoking healthy adult volunteers, smoking adult volunteers, pediatric patients with hemophilia A, and pediatric patients on ECMO/hemodialysis. The results of this study indicate that the values of i-QATT parameters MCF (maximum clot firmness), CIT (clot initiation time), and RT (reaction time) were strongly correlated with fibrinogen concentration and lab values obtained by gold-standard plasma tests (aPTT, PT) and viscoelastic hemostatic assays (ROTEM). Reference ranges for these parameters ruled out abnormal coagulation caused by factor deficiency, heparin, antiplatelet agents (Cytochalasin-D), or fibrinogen spiking. In the ATS technique, RT measured from the WB viscosity data demonstrated a strong correlation with plasma PT/aPTT. Linear correlation was obtained between the WB MCF output and the fibrinogen concentration. Acoustic tweezing coagulometry enables comprehensive drop-of-blood coagulation analysis that rapidly detects hypo- and hyper-coagulable states and measures PT, aPTT, and fibrinogen in WB or hemolyzed plasma samples.
No takes yet. Share an insight, caveat, or question.
Pham et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: